ADQ launches global pharmaceutical holding firm Arcera

ADQ launches global pharmaceutical holding firm Arcera

UAE – Mubasher: ADQ, an Abu Dhabi-based investment and holding company, has established a new global holding company under the name of Arcera to operate in the life sciences sector.

Located in Abu Dhabi, Arcera is planned to offer products that improve the quality and longevity of human life, according to a press release.

ADQ transferred its shareholdings in three companies to Arcera. These companies are Acino International (Acino), a pharmaceutical company headquartered in Switzerland; Birgi Mefar Group (BMG), a Turkish sterile production service company; and Amoun Pharmaceutical Company (Amoun), an Egypt-based pharmaceutical manufacturer.

Arcera has a total workforce of more than 6,500 people. The company will sell and distribute 2,000 branded medicines across a wide range of therapeutic areas in over 90 countries across four continents.

The new company is planning to double its revenue over the next five years through strategic acquisitions in key markets globally, as well as partnerships.

Hamad Al Hammadi, Deputy CEO of ADQ, said: “By consolidating our life sciences companies under one umbrella, Arcera signifies a strategic evolution, unlocking substantial portfolio value and reinforcing our commitment to innovation, globalisation and digitisation, which are key growth levers in this industry.”

“Arcera is positioned to be a significant contributor to Abu Dhabi's